Karp Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,536
| Closed | -$2.52M | – | 42 |
|
|
2022
Q3 | $2.52M | Buy |
+21,536
| New | +$2.52M | 0.52% | 50 |
|
|
2019
Q2 | – | Sell |
-45,624
| Closed | -$5.1M | – | 108 |
|
|
2019
Q1 | $5.1M | Buy |
45,624
+1,280
| +3% | +$143K | 1.81% | 16 |
|
|
2018
Q4 | $4.28M | Sell |
44,344
-712
| -2% | -$68.7K | 2.04% | 14 |
|
|
2018
Q3 | $5.49M | Sell |
45,056
-565
| -1% | -$68.9K | 1.89% | 13 |
|
|
2018
Q2 | $5.01M | Buy |
45,621
+680
| +2% | +$74.7K | 1.97% | 14 |
|
|
2018
Q1 | $4.8M | Buy |
44,941
+2,470
| +6% | +$264K | 1.93% | 13 |
|
|
2017
Q4 | $4.54M | Buy |
42,471
+2,811
| +7% | +$300K | 1.92% | 13 |
|
|
2017
Q3 | $4.41M | Buy |
39,660
+2,265
| +6% | +$252K | 2.05% | 11 |
|
|
2017
Q2 | $3.87M | Buy |
37,395
+6,600
| +21% | +$682K | 1.91% | 15 |
|
|
2017
Q1 | $3.01M | Buy |
30,795
+5,037
| +20% | +$492K | 1.7% | 25 |
|
|
2016
Q4 | $2.28M | Sell |
25,758
-810
| -3% | -$71.7K | 1.5% | 30 |
|
|
2016
Q3 | $2.56M | Buy |
26,568
+12,885
| +94% | +$1.24M | 1.64% | 24 |
|
|
2016
Q2 | $1.17M | Sell |
13,683
-525
| -4% | -$45K | 0.78% | 51 |
|
|
2016
Q1 | $1.24M | Sell |
14,208
-2,340
| -14% | -$203K | 0.85% | 53 |
|
|
2015
Q4 | $1.87M | Buy |
16,548
+13,170
| +390% | +$1.49M | 1.08% | 39 |
|
|
2015
Q3 | $342K | Buy |
3,378
+2,175
| +181% | +$220K | 0.23% | 71 |
|
|
2015
Q2 | $148K | Buy |
1,203
+240
| +25% | +$29.5K | 0.1% | 107 |
|
|
2015
Q1 | $110K | Buy |
963
+225
| +30% | +$25.7K | 0.07% | 129 |
|
|
2014
Q4 | $75K | Buy |
+738
| New | +$75K | 0.05% | 144 |
|